Menu Search
Equities

Viemed Healthcare Inc

VIJ:FRA

Viemed Healthcare Inc

Actions
  • Price (EUR)8.05
  • Today's Change0.05 / 0.63%
  • Shares traded730.00
  • 1 Year change+14.18%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 07:11 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).

  • Revenue in USD (TTM)214.30m
  • Net income in USD10.43m
  • Incorporated2016
  • Employees996.00
  • Location
    Viemed Healthcare Inc625 E. KALISTE SALOOM RD.LAFAYETTE 70508United StatesUSA
  • Phone+1 (337) 504-3802
  • Fax+1 (337) 500-1972
  • Websitehttps://www.viemed.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		VMD:NAQ since
announced		Transaction
value
East Alabama HomeMed LLCDeal completed01 Apr 202401 Apr 2024Deal completed-8.27%--
Data delayed at least 15 minutes, as of Nov 22 2024 20:39 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.